Processes for preparing jak inhibitors and related intermediate compounds
AssigneesIncyte Holdings Corporation, Incyte Corporation
InventorsJiacheng Zhou, James D. Rodgers, Haisheng Wang
Life of this patent
Estimating the term…
Abstract
The present invention is related to processes for preparing chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines of Formula III, and related synthetic intermediate compounds. The chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines are useful as inhibitors of the Janus Kinase family of protein tyrosine kinases (JAKs) for treatment of inflammatory diseases, myeloproliferative disorders, and other diseases.
Claims13
1-92. (canceled)
A process of preparing a composition comprising an enantiomeric excess of equal to or greater than 90% of the (R)-enantiomer of a compound of formula III′:
- comprising:
- (a) treating a compound of Formula XI′:
- with sodium hydride and N-pivaloyloxymethyl chloride to form a compound of Formula X′:
- (b) treating said compound of Formula X′ with a compound of Formula XIII′:
- in the presence of Pd(triphenylphosphine)4, potassium carbonate, and a solvent, to form a compound of Formula XII′:
- (c) reacting said compound of Formula XII′ under deprotection conditions to give a compound of Formula IV′:
- (d) reacting said compound of Formula IV″ with a compound of Formula XIV′:
- in the presence of 1,8-diaza-bicyclo[5.4.0]undec-7-ene to give a compound of Formula II′:
- (e) reacting said compound of Formula II′ with hydrogen gas in the presence of [Rh(COD)2]CF3SO3 and a chiral phosphine ligand selected from:
- to form a compound of Formula I′:
- and
- (f) reacting said compound of Formula I′ under deprotection conditions to form said compound of Formula III′;
- wherein * indicates a chiral carbon.
98-105. (canceled)
Dependencies are inferred from the claim text.